Ubs Group Ag Editas Medicine, Inc. Transaction History

Ubs Group Ag

  • $611 Billion
  • Q3 2025

A detailed history of Ubs Group Ag transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 422,394 shares of EDIT stock, worth $1.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
422,394
Previous 630,359 32.99%
Holding current value
$1.1 Million
Previous $1.39 Million 5.7%
% of portfolio
0.0%
Previous 0.0%

Shares

35 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025
SELL
$2.2 - $3.52 $457,523 - $732,036
-207,965 Reduced 32.99%
422,394 $1.47 Million
Q2 2025

Aug 14, 2025
SELL
$0.98 - $2.35 $574,294 - $1.38 Million
-586,015 Reduced 48.18%
630,359 $1.39 Million
Q1 2025

May 13, 2025
BUY
$1.14 - $3.2 $115,475 - $324,140
101,294 Added 9.08%
1,216,374 $1.41 Million
Q4 2024

Feb 14, 2025
BUY
$1.2 - $3.76 $845,365 - $2.65 Million
704,471 Added 171.57%
1,115,080 $1.42 Million
Q3 2024

Nov 14, 2024
BUY
$3.39 - $5.96 $232,174 - $408,188
68,488 Added 20.02%
410,609 $1.4 Million
Q2 2024

Aug 13, 2024
SELL
$4.67 - $7.28 $1.19 Million - $1.85 Million
-253,844 Reduced 42.59%
342,121 $1.6 Million
Q1 2024

May 13, 2024
BUY
$7.03 - $11.07 $3.18 Million - $5 Million
451,956 Added 313.84%
595,965 $4.42 Million
Q4 2023

Feb 09, 2024
BUY
$6.25 - $11.11 $219,793 - $390,705
35,167 Added 32.31%
144,009 $1.46 Million
Q3 2023

Nov 09, 2023
SELL
$6.92 - $9.31 $531,449 - $714,998
-76,799 Reduced 41.37%
108,842 $848,000
Q2 2023

Aug 11, 2023
SELL
$6.36 - $11.47 $1.99 Million - $3.58 Million
-312,223 Reduced 62.71%
185,641 $1.53 Million
Q1 2023

May 12, 2023
BUY
$7.03 - $11.53 $638,675 - $1.05 Million
90,850 Added 22.32%
497,864 $3.61 Million
Q4 2022

Feb 08, 2023
BUY
$8.32 - $13.21 $2.65 Million - $4.2 Million
318,113 Added 357.83%
407,014 $3.61 Million
Q3 2022

Nov 10, 2022
SELL
$12.16 - $19.42 $2.33 Million - $3.73 Million
-191,963 Reduced 68.35%
88,901 $1.09 Million
Q2 2022

Aug 10, 2022
BUY
$9.99 - $21.35 $392,417 - $838,649
39,281 Added 16.26%
280,864 $3.32 Million
Q1 2022

May 16, 2022
BUY
$14.08 - $27.63 $1.41 Million - $2.77 Million
100,148 Added 70.81%
241,583 $4.6 Million
Q4 2021

Feb 14, 2022
BUY
$26.55 - $40.57 $1.22 Million - $1.86 Million
45,839 Added 47.95%
141,435 $3.76 Million
Q3 2021

Nov 15, 2021
SELL
$39.27 - $72.94 $190,263 - $353,394
-4,845 Reduced 4.82%
95,596 $3.93 Million
Q2 2021

Aug 13, 2021
BUY
$31.29 - $56.64 $1.35 Million - $2.44 Million
43,110 Added 75.19%
100,441 $5.69 Million
Q1 2021

May 12, 2021
SELL
$39.71 - $90.58 $1.22 Million - $2.79 Million
-30,804 Reduced 34.95%
57,331 $2.41 Million
Q4 2020

Feb 11, 2021
BUY
$27.07 - $84.35 $699,001 - $2.18 Million
25,822 Added 41.44%
88,135 $6.18 Million
Q3 2020

Nov 12, 2020
SELL
$28.06 - $37.16 $193,754 - $256,589
-6,905 Reduced 9.98%
62,313 $1.75 Million
Q2 2020

Jul 31, 2020
BUY
$18.5 - $34.34 $233,137 - $432,752
12,602 Added 22.26%
69,218 $2.05 Million
Q1 2020

May 01, 2020
SELL
$14.88 - $32.78 $607,386 - $1.34 Million
-40,819 Reduced 41.89%
56,616 $1.12 Million
Q4 2019

Feb 14, 2020
SELL
$19.49 - $32.63 $2.74 Million - $4.59 Million
-140,570 Reduced 59.06%
97,435 $2.89 Million
Q3 2019

Nov 14, 2019
BUY
$22.49 - $26.81 $2.7 Million - $3.22 Million
120,159 Added 101.96%
238,005 $5.41 Million
Q2 2019

Aug 14, 2019
SELL
$20.48 - $27.76 $213,688 - $289,647
-10,434 Reduced 8.13%
117,846 $2.92 Million
Q1 2019

May 14, 2019
BUY
$19.43 - $26.41 $556,941 - $757,016
28,664 Added 28.77%
128,280 $3.14 Million
Q4 2018

Feb 14, 2019
SELL
$18.19 - $31.79 $556,086 - $971,852
-30,571 Reduced 23.48%
99,616 $2.27 Million
Q3 2018

Nov 14, 2018
BUY
$27.65 - $38.39 $998,247 - $1.39 Million
36,103 Added 38.37%
130,187 $4.14 Million
Q2 2018

Aug 14, 2018
SELL
$31.4 - $41.01 $3.77 Million - $4.92 Million
-119,954 Reduced 56.04%
94,084 $3.37 Million
Q1 2018

May 15, 2018
BUY
$29.84 - $44.08 $3.07 Million - $4.54 Million
102,947 Added 92.67%
214,038 $7.1 Million
Q4 2017

Feb 14, 2018
SELL
$21.89 - $31.34 $945,910 - $1.35 Million
-43,212 Reduced 28.0%
111,091 $3.41 Million
Q3 2017

Nov 14, 2017
BUY
$15.81 - $24.01 $991,239 - $1.51 Million
62,697 Added 68.44%
154,303 $3.71 Million
Q2 2017

Aug 14, 2017
BUY
N/A
13,389 Added 17.12%
91,606 $1.54 Million
Q1 2017

Nov 14, 2017
BUY
N/A
78,217
78,217 $1.75 Million

Others Institutions Holding EDIT

# of Institutions
217
Shares Held
48M
Call Options Held
637K
Put Options Held
292K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $179M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email